- Online: Visit www.musc.edu/cme and select “CME Conferences” on the left hand side, then scroll down to find this activity, select the blue “Register” button, and follow directions as prompted
- By Mail: Mail registration form (found on page six of the brochure - click here) with check made out to “Medical University of South Carolina” or credit card information to Elizabeth Gossen, Office of CME, Medical University of South Carolina, 96 Jonathan Lucas Street, HE221A, MSC 754, Charleston, SC, 29425
- Telephone: (843) 876-1925 – Registration by credit card only
- Fax: (843) 876-1931 – Registration by credit card only
Date: May 24, 2018 07:15 AM - May 26, 2018 12:15 PM
CE Hours
CE Units
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
- Describe the current data on the use and abuse of opioids in the US
- Accurately assess patients with pain for consideration of an opioid trial
- Establish realistic goals for pain management and restoration of function
- Initiate and titrate opioid treatment (IR and ER/LA) safely and judiciously, maximizing efficacy while minimizing risks
- Monitor and re-evaluate treatment continuously; discontinue safely when appropriate
- Counsel patients and caregivers about use, potential adverse effects, misuse, abuse, diversion and overdose
- Educate patients about safe storage and disposal of opioids
Speaker(s)/Author(s)
C. Wayne Weart, PharmD, FASHP, FAPhA
|
Activity Number
0062-9999-18-137-L01-PCE Hours
- Recall the 2017 ACC/AHA hypertension guideline new definition of hypertension and how it changes the US population at risk for hypertension
- Recognize how to properly take BP and the importance of accurate BP measurement
- Recognize when to implement lifestyle modification in the treatment of hypertension
- Recall the current first-line agents for the treatment of hypertension
- Recognize what BP goal (target) is recommended to best improve CV outcome in specific patient populations with hypertension
Speaker(s)/Author(s)
Jan Basile, MD
|
Activity Number
0062-9999-18-053-L01-PCE Hours
- Identify symptoms and signs that suggest the presence of NAFLD
- Recognize sequelae of chronic NAFLD
- Describe the basic foundations of NAFLD treatment
Speaker(s)/Author(s)
Don C. Rockey, MD
|
Activity Number
0062-9999-18-054-L01-PCE Hours
- Demonstrate how to effectively use language that is sensitive to the needs and experiences of transgender individuals
- Perform primary and preventive care for transgender patients
Speaker(s)/Author(s)
Marty Player, MD, MSCR
|
Activity Number
0062-9999-18-055-L01-PCE Hours
- Review newer antidepressants and their role in therapy
- Discuss important considerations in the selection of antidepressant therapy
- Summarize evidence-based recommendations to optimize treatment outcomes
- Apply presented data and clinical pearls to a patient case
Speaker(s)/Author(s)
Sophie Robert, BPharm, PharmD, BCPP
|
Activity Number
0062-9999-18-056-L01-PCE Hours
- Recognize and apply the collaborative, patient-centered spirit of MI (acronym: RULE) to medication adherence
- Recognize and apply specific MI communication skills (acronym: OARS) to medication adherence
Speaker(s)/Author(s)
John Freedy, MD, PhD
|
Activity Number
0062-9999-18-057-L04-PCE Hours
- Engage in shared decision-making conversations regarding prostate cancer in higher-risk men
- Discuss prostate cancer disparities with patients
- Access United States Preventive Services Task Force prostate cancer screening guidelines
- Manage or appropriately refer abnormal prostate screening results
- Discuss prostate cancer treatments with specialist colleagues
Speaker(s)/Author(s)
Nicholas Shungu, MD
|
Activity Number
0062-9999-18-060-L01-PCE Hours
- Describe distinguishing characteristics among currently available stimulant preparations
- List notable potential risks and benefits of utilizing stimulants for various diagnoses encountered in the primary care setting including: ADHD, depression, apathy, and narcolepsy
- Apply presented information and clinical pearls to select appropriate pharmacotherapy and monitoring parameters
Speaker(s)/Author(s)
Clint Ross, PharmD, BCPP
|
Activity Number
0062-9999-18-059-L01-PCE Hours
- Assess the available guidelines for tobacco cessation
- Evaluate the effectiveness and safety of medications used in the treatment of tobacco use disorder based on the latest clinical trials and extant evidence
- Discuss the use of electronic nicotine delivery systems (ENDS) in tobacco cessation, based on the new National Academy of Medicine report
- Identify cessation resources available on-line and in the community
Speaker(s)/Author(s)
Katherine Hoover, PharmD, BCPS
|
Activity Number
0062-9999-18-058-L01-PCE Hours
- Interpret spirometry
- Adjust medication classes on the basis of both symptoms and exacerbation frequency
- Improve medication compliance in their patients by better understanding the definition of an exacerbation
- Determine when a CT scan is indicated for obstructive lung diseases
Speaker(s)/Author(s)
Charles Strange, MD
|
Activity Number
0062-9999-18-061-L01-PCE Hours
- Incorporate spirometry into the definition of asthma to improve the specificity of diagnosis
- Discuss with patients the removal of boxed warnings from some inhalers but not others regarding increased risk of asthma death
- Develop a checklist for patients who are poorly controlled on current asthma therapy
- Determine when to refer patients for omalizumab, mepulizamab, and benralizumab injections
Speaker(s)/Author(s)
Charles Strange, MD
|
Activity Number
0062-9999-18-062-L01-PCE Hours
- Identify the appropriate use of HRT
- Discuss the timing of HRT and its safety
- Recognize the risks of HRT
Speaker(s)/Author(s)
Donald Fylstra, MD
|
Activity Number
0062-9999-18-063-L01-PCE Hours
- Select appropriate treatment options for patients with glaucoma and other common ophthalmic conditions
- Design a treatment plan for an adult and pediatric patient with an ophthalmic condition
- List side effects and important counseling points for ophthalmic medications
Speaker(s)/Author(s)
Morgan Adams, PharmD, BCACP
|
Activity Number
0062-9999-18-064-L01-PCE Hours
- Discuss treatment considerations in migraine
- Describe pathophysiology of migraine yesterday and today
Speaker(s)/Author(s)
Aljoeson Walker, MD
|
Activity Number
0062-9999-18-052-L01-PCE Hours
- Address the barriers and difficulties encountered while staying current with new medical data and trends
- Evaluate traditional and modern resources that simplify information gathering
- Discuss technology's impact on continuing education
- Explore new opportunities available for professionals seeking to provide education in their field.
Speaker(s)/Author(s)
Michael Corvino, PharmD, CDE
|
Activity Number
0062-9999-18-066-L04-PCE Hours
- Identify and evaluate new FDA-approved type 2 diabetes mellitus agents and recent literature regarding type 2 diabetes mellitus
- Compare and contrast the latest type 2 diabetes mellitus agents and literature findings with current standards of care
- Integrate recent evidence-based recommendations into clinical practice
Speaker(s)/Author(s)
Emmeline Tran, PharmD, BCPS
|
Activity Number
0062-9999-18-067-L01-PCE Hours
- Recognize common dermatologic conditions and their treatments
Speaker(s)/Author(s)
Richard Marchell, MD
|
Activity Number
0062-9999-18-068-L01-PCE Hours
- Identify intervals to draw labs and consult nephrology
- Manage common complications of chronic kidney disease
- Minimize decline in renal function with chronic kidney disease
Speaker(s)/Author(s)
Scott Bragg, PharmD, BCPS
|